# Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)

> **NCT02770885** · PHASE2 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 50 (actual)

## Conditions studied

- Primary Polydipsia

## Interventions

- **DRUG:** Dulaglutide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02770885
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2019-05-17
- **Final completion:** 2019-10-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02770885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02770885, "Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02770885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*